Geneos Wealth Management Inc. Ab Cellera Biologics Inc. Transaction History

Geneos Wealth Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.46 - $14.14 $1,492 - $2,828	-200 Reduced 1.94%	10,087 $98,000
Q4 2021 Feb 09, 2022	SELL	$12.99 - $17.73 $649 - $886	-50 Reduced 0.48%	10,287 $147,000
Q3 2021 Nov 09, 2021	BUY	$14.85 - $21.34 $29,655 - $42,615	1,997 Added 23.94%	10,337 $177,000
Q2 2021 Jul 08, 2021	BUY	$20.19 - $34.17 $5,047 - $8,542	250 Added 3.09%	8,340 $170,000
Q1 2021 Jun 17, 2021	SELL	$23.29 - $53.2 $293,919 - $671,384	-12,620 Reduced 60.94%	8,090 $215,000
Q4 2020 May 19, 2021	BUY	$39.0 - $58.9 $807,690 - $1.22 Million	20,710 New	20,710 $560,000

155

108M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $884M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.